1 Product identity
Ingredient risk
Not yet assessed
Adreno-Lyph-160
BrandNutri-West→Non-Nutrient/Non-Botanical Tablet or Pill 3 ingredients DSLD #27510Net contents: 60 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2013-11-25
2 Ingredients (3)
IngredientGroupSafety
161 mg of bovine tissue concentrates fromBovine (unspecified)—
AdrenalAdrenals—
ParotidParotid—
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
4 Label claims
• All Other
5 Data source
DSLD ID27510
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2013-11-25
6 More from Nutri-West
View Nutri-West Safety Scorecard → 186 products
#1 - AD#2 - CFAdreno - Lyph - SymAdreno-Lyph 80Adreno-Lyph-ParaAdreno-Lyph-Plus7 Cite this page
Vancouver
Pkhakadze G. Adreno-Lyph-160 — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 25]. Available from: https://supplement.ge/products/adreno-lyph-160-27510/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG